Claudin-6

Claudin-6 분자 정보

영어 이름Claudin 6시판 약물 수0
임상 약물 수13표적 별명UNQ757/PRO1488,Claudin-6,CLDN6,Claudin 6,Skullin
최고 연구 개발 단계Phase 2 Clinical
영어 이름Claudin 6
표적 별명UNQ757/PRO1488,Claudin-6,CLDN6,Claudin 6,Skullin
시판 약물 수0
임상 약물 수13
최고 연구 개발 단계Phase 2 Clinical

Claudin-6분자 배경

Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. Claudin-6, also knows as CLDN6, is a multipass transmembrane protein in the Claudin family. Claudin-6 is expressed by epithelial cells where it participates in tissue development and the maintenance of tight junction integrity. And it is one of the entry cofactors for hepatitis C virus. The methylation of CLDN6 may be involved in esophageal tumorigenesis. The gene of CLDN6 is adjacent to another family member CLDN9 on chromosome 16.

Claudin-6분자 별명

Claudin-6,CLDN6

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
CLDN6 mAb - 01PCCMonoclonalHumanized MouseSolid TumorOvarian cancer,Lung adenocarcinoma

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
QLS-5132QLS5132; QLS-5132Phase 2 ClinicalQilu Pharmaceutical Co LtdCarcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms
상세
TORL-1-23TORL-1-23Phase 2 ClinicalTorl Biotherapeutics LLCCarcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Fallopian Tube Diseases; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Diseases; Peritoneal Neoplasms; Solid tumours
상세
PLB-002PLB-002; PLB002Phase 1 ClinicalPrimeLink BioTherapeuticsEndometrial Neoplasms; Ovarian Neoplasms; Solid tumours; Testicular Neoplasms
상세
BGB-B455BGB-B455Phase 1 ClinicalBeOne Medicines LtdSolid tumours
상세
AT03-65AT-03-65; AT03-65Phase 1 ClinicalAxcynsis Therapeutics Pte LtdSolid tumours
상세
ARC-101ARC101; ARC-101Phase 1 ClinicalThird Arc Bio IncEndometrial Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Solid tumours
상세
CTIM-76CTIM-76Phase 1 ClinicalIntegral Molecular IncEndometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Testicular Neoplasms
상세
NBL-028NBL028; NBL-028Phase 1 ClinicalNovarock Biotherapeutics Ltd, Shanghai Xinshi Biological Medicine Co LtdCarcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Testicular Neoplasms
상세
XmAb-541XmAb541; XmAb-541Phase 1 ClinicalXencor IncEndometrial Neoplasms; Germinoma; Neoplasms, Germ Cell and Embryonal; Ovarian germ cell tumor; Ovarian Neoplasms
상세
SAIL-66SAIL66; SAIL-66Phase 1 ClinicalChugai Pharmaceutical Co LtdSolid tumours
상세
CLDN6-CAR-NK Cell TherapyPhase 1 ClinicalSecond Affiliated Hospital Of Guangzhou Medical UniversityEndometrial Neoplasms; Ovarian Neoplasms
상세
TJ-C64BTJ-C64BPhase 1 ClinicalI-Mab Biopharma Co LtdOvarian Neoplasms; Stomach Neoplasms
상세
CLDN6 CAR-T cell therapy (BioNTech)BNT-211Phase 1 ClinicalBiontech SeGerminoma; Neoplasms, Gonadal Tissue; Solid tumours; Testicular Neoplasms
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호